Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
74.76
-0.60
(-0.80%)
At close: February 21 at 8:05:17 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | 1.06B | 1.05B | 4.29B | 4.44B |
| Low Estimate | 1.05B | 1.05B | 4.24B | 4.39B |
| High Estimate | 1.07B | 1.07B | 4.33B | 4.49B |
| Year Ago Sales | 1.05B | 1.03B | 4.19B | 4.29B |
| Sales Growth (year/est) | 1.49% | 1.96% | 2.51% | 3.47% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SVC.F | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.50% | 10.82% | 14.15% |
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 12/13/2024 |
| Maintains | Raymond James: Outperform to Outperform | 11/1/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/1/2024 |
| Maintains | Truist Securities: Buy to Buy | 6/21/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/22/2024 |
| Maintains | UBS: Buy to Buy | 5/17/2024 |